Central adiposity determines prevalence differences of the metabolic syndrome

Obesity Research

Volumn 11, Issue 12, 2003, Pages 1480-1487

  Lorenzo, Carlos ^a   Serrano Ríos, Manuel ^b   Martínez Larrad, María T ^b   Gabriel, Rafael ^c   Williams, Ken ^a   Gómez Gerique, Juan A ^d   Stern, Michael P ^a   Haffner, Steven M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Central obesity; Epidemiology; Glucose tolerance; Lipids; Metabolic syndrome

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; BODY CONSTITUTION; CAUCASIAN; COMPARATIVE STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PREVALENCE; RURAL POPULATION; SEX DIFFERENCE; SPAIN; STATISTICAL MODEL; UNITED STATES; URBAN POPULATION;

ADIPOSE TISSUE; ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY CONSTITUTION; CHOLESTEROL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RURAL POPULATION; SEX FACTORS; SPAIN; TEXAS; TRIGLYCERIDES; URBAN POPULATION;

EID: 2142855638     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2003.198     Document Type: Article

References (31)

1. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-9.
2. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-16.
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
4. Kue Young T, Chateau D, Zhang M. Factor analysis of ethnic variation in the multiple metabolic (insulin resistance) syndrome in three Canadian populations. Am J Human Biol. 2002;14:649-58.
5. Okosun IS, Liao Y, Rotimi CN, Prewitt TE, Cooper RS. Abdominal adiposity and clustering of multiple metabolic syndrome in white, black and Hispanic Americans. Ann Epidemiol. 2000;10:263-70.
6. Alvarez Leon EE, Ribas Barba L, Serra Majem L. Prevalence of the metabolic syndrome in the population of Canary Islands, Spain. Med Clin. 2003;120:172-4.
7. Balkau B, Charles MA, Drivsholm T, et al. European Group for the Study of Insulin Resistance (EGIR): frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 2002;28:364-76.
8. Hazuda HP, Comeaux PJ, Stern MP, Haffner SM, Eifler CW, Rosenthal M. A comparison of three indicators for identifying Mexican Americans in epidemiologic research: methodological findings from the San Antonio Heart Study. Am J Epidemiol. 1986;123:96-112.
9. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA. 1994;272:205-11.
10. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76-9.
11. Burke JP, Williams K, Gaskill SP, Hazuda HP, Haffner SM, Stern MP. Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Intern Med. 1999;159:1450-6.
12. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, et al. Was the historic contribution of Spain to the Mexican Gene pool partially responsible for the higher prevalence of type 2 diabetes in Mexican-origin populations? Diabetes Care. 2001;24:2059-64.
13. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, et al. Prevalence of hypertension in Hispanic and non-Hispanic white populations. Hypertension. 2002;39:203-8.
14. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ. Sex differences in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study. Am J Epidemiol. 1984;120:834-51.
15. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus. N Engl J Med. 1986;315:220-4.
16. Haffner SM, Miettinen H, Gaskill SP, Stern MP. Metabolic precursors of hypertension: the San Antonio Heart Study. Arch Intern Med. 1996;156:1994-2001.
17. Haffner SM, Mitchell BD, Stern MP, et al. Decreased prevalence of hypertension in Mexican-Americans. Hypertension. 1990;16:225-32.
18. World Health Organization Department of Noncommunicable Disease Surveillance. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva, Switzerland: World Health Organization; 1999.
19. Johnson CL, Rifkind BM, Sempos CT, et al. Declining serum total cholesterol levels among US adults: the National Health and Nutrition Examination Surveys. JAMA. 1993;269:3002-8.
20. Arnett DK, McGovern PG, Jacobs DR Jr., et al. Fifteen-year trends in cardiovascular risk factors (1980-1982 through 1995-1997): the Minnesota Heart Survey. Am J Epidemiol. 2002;156:929-35.
21. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9.
22. Sans S, Paluzie G, Balana L, Puig T, Balaguer-Vintro I. Trends in prevalence, awareness, treatment and control of arterial hypertension between 1986 and 1996: the MONICA-Catalonia study. Med Clin. 2001;117:246-53.
23. Paluzie G, Sans S, Balana L, Puig T, Gonzalez-Sastre F, Balaguer-Vintro II. [Secular trends in smoking according to educational level between 1986 and 1996: the MONICA study. Catalonia.] Gac Sanit. 2001;15:303-11.
24. Villar Alvarez F, Banegas Banegas JR, Rodriguez Artalejo F, del Rey Calero J. Cardiovascular mortality in Spain and its autonomous communities (1975-1992). Med Clin. 1998;110:321-7.
25. Rodriguez Artalejo F, Lopez Garcia E, Gutierrez-Fisac JL, Banegas Banegas JR, Lafuente Urdinguio PJ, Dominguez Rojas V. Changes in the prevalence of overweight and obesity and their risk factors in Spain, 1987-1997. Prev Med. 2002;34:72-81.
26. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP): NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003;52:1210-4.
27. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-93.
28. Lemieux I, Pascot A, Couillard C, et al. Hypertriglyceridemic Waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000;102:179-84.
29. Meigs JB, D'Agostino RB, Wilson PW, et al. Risk variable clustering in the insulin resistance syndrome: the Framingham Offspring Study. Diabetes. 1997;46:1594-600.
30. Ministerio de Educación Cultura y Deporte, Secretaría General de Educación y Formación Profesional. Sistema Estatal de Indicadores de la Educación. Madrid, Spain: Instituto Nacional de Calidad y Evaluación; 2000.
31. von Eckardstein A, Schulte H, Assmann G. Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Munster. J Clin Endocrinol Metab. 2000;85:3101-8.